Abstract (232 words) Cyclopropylamines, inhibitors of monoamine oxidases (MAO) and lysine-specific demethylase (LSD1), provide a useful structural scaffold for the design of mechanism-based inhibitors for the therapy of depression and cancer. For new compounds with the less common cis relationship and with an alkoxy substituent at the 2-position of the cyclopropyl ring, the apparent affinity from docking revealed little difference between the enantiomers. Using the racemate, kinetic parameters for the reversible and irreversible inhibition of MAO were determined. No inhibition of LSD1 was 
Introduction
Interest in cyclopropylamine chemistry was revived when tranylcypromine (TCP; trans-2-phenylcyclopropan-1-amine) was identified as an irreversible inhibitor of LSD1, one of the key demethylase enzymes in epigenetic gene regulation [1, 2] . TCP is a mechanism-based inactivator of monoamine oxidases (MAO) and has been used in the treatment of depression for decades [3] [4] [5] .
TCP inactivates MAO B by forming the C4a adduct with the flavin cofactor whereas LSD1 forms the N5 adduct [5, 6] . These adducts are formed after the oxidation of tranylcypromine by the enzyme, and each may arise via a C4a-N5 cyclic structure [6] [7] [8] . A new series of 1-substituted cyclopropylamine derivatives with improved affinity for LSD1 formed different adducts depending on the derivative, at C4a, N5, or bridging both, probably via a radical mechanism [9] . The inactivation is irreversible so new protein synthesis is required for the restoration of activity in the cell.
The potential usefulness of cyclopropylamine inhibitors of MAO and LSD1 for the therapy of depression [10] [11] [12] and cancer [4, [13] [14] [15] [16] [17] , and the need for selective inhibition of the targets has prompted the synthesis and evaluation of new inhibitors such as trans 1-substituted derivatives [9] .
For the MAO enzymes, more derivatives of trans-isomers have been studied, but cis-2-phenylcyclopropylamine is only slightly less effective than the trans-isomer [18] [19] [20] . Enantiomeric selectivity is also a concern. On MAO B, the 1R,2S-(-)-TCP was 20-fold more effective as a competitive inhibitor, but cis-2-phenylcyclopropylamine showed no enantiomeric selectivity [4, 5, 21] . LSD1 showed no enantiomeric selectivity for TCP [5, 22] , but the two enantiomers of a 1-substituted cyclopropylamine gave different adducts [9] .
Here we report the inhibition of the two forms of MAO by selected cis-isomers of primary and secondary cyclopropylamines with an alkoxy group at the 2-position of the cyclopropyl ring replacing the more common phenyl substitution [23] . The trans-compound TCP, already wellestablished as a drug before the full impact of two forms of MAO was appreciated [21, 24, 25] , is included as a reference compound. We show that cis-cyclopropylamine, like TCP, forms a covalent adduct with the flavin in MAO A and MAO B. Docking studies, performed to explore enantiomer binding in MAO A and MAO B, also revealed occupancy of the imidazoline (I2) site [26] [27] [28] in the entrance cavity of MAO B.
TABLE 1 HERE

Results
No inhibition of LSD1
The cis-cyclopropylamine compounds, synthesised as before [23] , were tested against LSD1 for which TCP is an established lead. In the LSD1 enzyme assay, the compounds were inactive at the maximum tested concentration of 25 µM.
Molecular modelling with MAO to explore enantiomeric selectivity
Reversible binding can be predicted by docking, so this was used to guide the selection of previously synthesised compounds [23] used in this study and then to explore whether the enantiomers might bind differently to MAO A and MAO B (Table 1 ). Molecular modelling [29] was performed to determine binding energies and estimated K i values for the cis-cyclopropylamines with MAO A and MAO B (Supplementary Table S1 ). Theoretical K i values for both enantiomers of all seven compounds were obtained by docking the compounds into MAO A (2Z5X) and MAO B (2V5Z) using Autodock [30] (as shown in Table 1 ) and Vina [31] . Both programmes gave concordant values for the binding energies with essentially no difference between the (1R,2S) and (1S,2R) enantiomers (Supplemental Table S1 ). The aromatic group improves binding energy, and the para-methyl group makes compounds 3 and 6 better than 4 in this theoretical ranking. The parachloro compound 7 gives values similar to the para-methyl one.
Based on the lack of enantiomeric differences, racemic cis-cyclopropylamines were used for the experimental work.
Reversible binding: Experimental IC 50 values
For MAO A and B, the reversible interaction was measured as IC50. Under the conditions of the assay used here, the IC50 values with MAO A are proportional to Ki and reflect the initial reversible binding of the inhibitor to MAO A [32] . For MAO B, the IC50 is influenced by the oxidative half-reaction as well as the reductive half reaction because the rates of reduction and reoxidation of the flavin in the steady state are similar. In practice, the affinity of the inhibitor for the reduced form of MAO B becomes significant, so that the experimental IC50 is influenced by more factors than is the true Ki for binding to a single (oxidised) form of MAO B [32] 
TABLE 3 HERE Kinetic parameters for inactivation of MAO A and MAO B by cis-cyclopropylamines
After pre-incubation with the enzyme, the inhibition by all four selected compounds (1, 3, 4, 6) was irreversible and the activity was not restored by dilution into excess substrate. The kinetic parameters for the mechanism-based irreversible inactivation of MAO A, termed K I and k inact [33] , were determined from the time course of inactivation and are presented in Table 3 . The MAO A irreversible K I values are all poor, with the exception of 4 ( Table 3 ). The K I values for MAO B indicate much more discrimination of the structural variations in the compounds: 4 (0.07 µM) < 1 (0.9 µM) < 3 (5 µM) < 6 (17 µM), presumably as a result of its narrower substrate cavity [34] . The specificity constants (k inact /K I ) provide a comparison of the efficiency of inactivation by each compound, and from them, the selectivity for MAO B compared to MAO A is calculated as a ratio (last column of Table 3 
FIGURE 1 HERE Characterization of the adduct formed between MAO A and 4
Covalent adducts with the N5 group of the FAD moiety of MAO, such as formed after inactivation by clorgyline or deprenyl, are characterised by a distinctive change in the spectrum of MAO that differs from that seen for the C4a adduct [35] [36] [37] [38] . The spectral changes that occur during adduct formation with cis-cyclopropylamines 4 were studied (Fig. 1) . The MAO A flavin absorbance at 456 nm was bleached indicating at least partial reduction of the flavin (Fig. 1A) . The absorbance at 400 nm increased but this increase lagged behind the rapid flavin reduction as seen in the time course (Fig. 1B) and in the difference spectra in Fig. 1C . This suggests a slower chemical step for adduct formation after the reduction of the flavin.
The spectral change during inactivation of MAO A by compound 4 has some similarity to that for N5 modification by clorgyline, but it has a less intense absorbance increase at 400 nm rather than the large 415 nm increase seen for N5 propargyl adducts with MAO A. However, the flavin remains reduced after denaturation with urea, suggesting that it is a stable adduct, unlike the labile adducts for trans-cyclopropylamines assumed to be at C4a [39] where reoxidation of the flavin is obvious after urea denaturation. Fig. 3 (left). The entrance cavity pose (Fig. 3, right) was found in only two of the ten Autodock runs for . This entrance cavity location (Fig. 3) is similar to that of 2-BFI bound in the imidazoline I 2 site of MAO B that has been characterised in binding studies and demonstrated by crystallography [26, 27] . However, unlike the I 2 ligands that have nM affinity, the predicted K i for binding of compound 1 at this location is in the micromolar range.
The low probability of binding close to the flavin may also explain the low rate of inactivation ( For MAO, although the initial binding is micromolar, these cis-cyclopropylamines inhibit MAO A and MAO B irreversibly at submicromolar levels, making them selective for MAO without an effect on LSD1. The best inhibition was observed with MAO B. Compound 4 is >20 times more effective than TCP, so this di-substituted cyclopropylamine (secondary amine) could be studied as a lead for selective inhibitors of MAO B that do not inhibit LSD1.
Both the primary (1, 2) and the secondary (3-7) amines can inactivate both MAO isoenzymes, confirming that cis-cyclopropylamines interact with MAO to form reactive products that can form a covalent bond to the flavin. The spectrum with MAO A during inactivation and the stability of the adduct formed during unfolding suggest that the modification by N-benzyl-2-methoxycyclopropylamine 4 may be at the N5 of the flavin. Although the crystal structure of MAO B after TCP inactivation shows C4a modification, the structure of LSD1 shows that TCP modifies the N5 of the flavin [5] . Recent crystal structures have revealed that some 1-substituted cyclopropylamines formed different adducts with LSD1 at C4a, N5, or bridging both, probably via a radical mechanism [9] . Others have also reported formation of a cyclic N5 and C4a adduct [6-8, 13, 22, 42 , 43], so perhaps both are possible even if only one form crystallizes. The spectrum of the adduct is not definitively that of an N5 adduct such as formed with clorgyline or deprenyl [35, 44] , so only the stability [39] favours that interpretation for this cis-cyclopropylamine. This work does not address the structure of the adduct nor the mechanism of adduct formation but the lack of H 2 O 2 production during inactivation of MAO A means that a radical mechanism proposed by others must be considered [9, 45] . 
Experimental procedures Compounds
The cis-isomers of primary and secondary cyclopropylamines with an alkoxy group at the 2-position of the cyclopropyl ring replacing the more common phenyl substitution were synthesized as previously described [23] .
Enzyme activity
Initial activity for membrane-bound MAO (Sigma-Aldrich, UK) was determined from the production of hydrogen peroxide, coupled to a dye via horseradish peroxidase producing Inactivation parameters (K I and k inact ) were determined as in [33, 38] . Data are expressed as value ± standard deviation (SD) obtained by fitting the data (at least 20 points) to the appropriate threeparameter equation using GraphPad PRISM 4. At least two separate determinations were made for each value reported.
Molecular Docking
Molecular models of the cis-cyclopropylamine inhibitors were built and optimised using ArgusLab and MAO B (PDB code: 2V5Z) protein structures were minimised using Accelrys 6.0 adopting a CHARMM force field and simulated annealing. All .pdbqt, .gpf ,and .dpf files where created using AutoDock tools software, adopting a Lamarckian genetic algorithm and converted to .glg and .dlg files using the AutoGrid4 and AutoDock4 coding sequences, respectively. Docking was achieved using AutoDock4 and Vina coding scripts. All comparisons were carried out using PyMOL. 
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